Reducing the use of proton pump inhibitors in infants with reflux symptoms

Størdal, Ketil; Ma, Amy; Beck, Carolyn E

doi:10.1136/bmj-2022-074588

BMJ

2024

DOI: 10.1136/bmj-2022-074588

|View full text |Cite

Reducing the use of proton pump inhibitors in infants with reflux symptoms

Ketil Størdal,

Amy Ma,

Carolyn E Beck

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prevalence and Patterns of Omeprazole and H2 Blocker Use in Neonates in a Neonatal Intensive Care Unit Setting

Iqbal,

Javed,

Quddus

et al. 2024

PJHS-Lahore

View full text Add to dashboard Cite

H2 blockers and omeprazole therapy have not been shown to improve clinical symptoms associated with stress ulceration in newborn trials. There were concerns regarding the reliability and efficacy of treating stress ulcers in adults and children with omeprazole and H2 blockers. Objective: To investigate the prevalence and patterns of H2 blocker and omeprazole use in neonates, assess their efficacy, and evaluate potential risks associated with their use. Methods: Sick infants admitted to NICUs within the Department of Pediatrics ‘Sheikh Khalifa Bin Zaid Al Nahyan Hospital’, Rawalakot, Azad Kashmir were included in this retrospective study. Data collection was done from the hospital records from January 2022 to December 2022. All NICU infants who were at least 28 days old, were critically sick participated in this investigation. Results: There was a twice as high frequency of omeprazole use as of H2 blocker use. More frequently used drugs were Omeprazole and Cimetidine. That was from January to December in the year 2023 Omeprazole group rose from 3. 1% to 3. 8% and the H2 blocker group rose from 1. 3% to 1. 9%. Conclusions: Hospitalized neonates including those without GIT issues were commonly exposed to prescriptions of H2 blockers end Omeprazole. The findings depicted the need for controlling and effectively utilizing omeprazole and H2 blockers. Hence there was a need for more research in relation to the safety and efficacy of omeprazole and H2 blockers in infants.

show abstract

Prevalence and Patterns of Omeprazole and H2 Blocker Use in Neonates in a Neonatal Intensive Care Unit Setting

Iqbal,

Javed,

Quddus

et al. 2024

PJHS-Lahore

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Reducing the use of proton pump inhibitors in infants with reflux symptoms

Cited by 1 publication

References 35 publications

Prevalence and Patterns of Omeprazole and H2 Blocker Use in Neonates in a Neonatal Intensive Care Unit Setting

Prevalence and Patterns of Omeprazole and H2 Blocker Use in Neonates in a Neonatal Intensive Care Unit Setting

Contact Info

Product

Resources

About